Benitec Biopharma BNTC
NASDAQ BNTC
$8.65 -0.17 (-1.93%)
At close: Oct 23, 2026 · 4:00 PM EDT

Benitec Biopharma (BNTC) Return on Sales [ROS] (2019 - 2025)

Updated

Benitec Biopharma's Return on Sales [ROS] came in at -307028.57% for fiscal Q3 2024 (quarter ended Mar 31, 2024), down 298989.68 percentage points from -8038.89% a year earlier and down 271467.92 percentage points from the prior quarter.

Analysis

Benitec Biopharma (BNTC) Return on Sales [ROS] (2019 - 2025) Analysis & Trends

For FY2023 (ended Jun 30, 2023), Benitec Biopharma's Return on Sales [ROS] was -25441.33%, down 983.80 percentage points from FY2022.

  • Return on Sales [ROS] has declined in each of the last four fiscal years, with a four-year change of -25462.51 percentage points (FY2019 to FY2023).
  • Going back by fiscal year, Return on Sales [ROS] was -24457.53% in FY2022 (-1413.47 pp), -23044.07% in FY2021 (-14925.44 pp), -8118.63% in FY2020 (-8139.80 pp) and 21.17% in FY2019.
  • The fiscal Q3 2024 figure represents the lowest quarterly Return on Sales [ROS] since fiscal Q1 2022.
  • Year-over-year, Return on Sales [ROS] increased in three of the last eight quarters, with an average year-over-year change of +22220.93 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in fiscal Q3 2022 (a gain of 372091.67 percentage points), and the weakest in fiscal Q1 2022 (a drop of 388334.09 percentage points).
  • Business Quant data shows BNTC's Return on Sales [ROS] at -35560.66% (Q2 2024), -27166.67% (Q1 2024) and -65000.00% (Q4 2023) in the three fiscal quarters before Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.35%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 37.86%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -3.52%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 20.57%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -133.21%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 28.37%
10 Benitec Biopharma 402.73 Mn -158.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4,170.08%
Sep 30, 2025 -3,921.81%
Jun 30, 2025 -949.23%
Mar 31, 2024 -307,028.57%
Dec 31, 2023 -35,560.66%
Sep 30, 2023 -27,166.67%
Jun 30, 2023 -65,000.00%
Mar 31, 2023 -8,038.89%
Dec 31, 2022 -40,071.43%
Sep 30, 2022 -24,127.40%
Jun 30, 2022 -24,458.90%
Mar 31, 2022 -7,208.33%
Dec 31, 2021 -19,340.00%
Sep 30, 2021 -393,225.00%
Jun 30, 2021 -192,750.00%
Mar 31, 2021 -379,300.00%
Dec 31, 2020 -325,900.00%
Sep 30, 2020 -4,890.91%
Jun 30, 2020 -8,033.98%
Mar 31, 2020 -7,539.29%
API Access

Benitec Biopharma Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BNTC&period=max&api_key=YOUR_API_KEY